PI
ENZ

Putnam Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

Putnam Investments’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-583,350
Closed -$4.88M – 1318
2017
Q1 		$4.88M Buy
583,350
+258,548
+80% +$1.82M 0.01% 591
2016
Q4 		$2.25M Buy
+324,802
New +$2.07M 0.01% 815

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Putnam Investments's ENZ Position: Q2 2017 in Review

Putnam Investments sold out of Enzo Biochem, Inc. (ENZ) in Q2 2017, closing a stake of 583,350 shares — an estimated $4.88M sold.

Putnam Investments first reported a position in ENZ in Q4 2016 and held it in 2 quarters. The position peaked at $4.88M in Q1 2017. 120 funds tracked by Wall St. Rank hold ENZ as of Q2 2017.

  • Putnam Investments reported no remaining Enzo Biochem, Inc. position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 583,350 Enzo Biochem, Inc. shares in Q2 2017, an estimated $4.88M.
  • Putnam Investments first reported a position in Enzo Biochem, Inc. in Q4 2016 and held it in 2 quarters.
  • Putnam Investments's Enzo Biochem, Inc. position peaked at $4.88M in Q1 2017.
  • 120 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.